The PACULit Newsletter
Your Weekly Dose of Practice-Changing Pharmacy Evidence
Every week, we hand-pick the most impactful pharmacy studies, distill them into concise summaries, narrate them into 5-minute audio digests, and deliver them straight to your inbox — with ACPE-accredited CE credits built in.
Everything in One Weekly Digest
The PACULit Newsletter does the heavy lifting so you can stay current without the burnout. Here is what arrives in your inbox every week.
3 Curated Studies Per Week
Hand-picked, practice-changing research with pharmacy-focused summaries written by clinical pharmacists. Each study is selected for its direct impact on patient care and clinical decision-making — no fluff, no filler.
5-Minute Audio Summaries
Professional narrations for every study so you can learn during your commute, workout, or downtime. Each audio summary distills the key findings, methodology, and clinical implications into a focused, easy-to-absorb format.
CE Credits Built In
Earn ACPE-accredited continuing education credits simply by engaging with the literature. Read the summary, listen to the audio, complete a brief quiz, and your CE credits are automatically tracked in your PACU transcript.
What Every Newsletter Looks Like
Each study summary follows a structured, pharmacy-first format designed for rapid comprehension and immediate clinical application.
PACULit Newsletter
Weekly Evidence Digest
Full study title with complete journal citation, volume, issue, and DOI link
Journal Name. 2026;XX(X):XXX-XXX. doi:10.XXXX/XXXXX
Pharmacy-relevant distillation of the study’s primary and secondary outcomes, statistical significance, effect sizes, and how the results compare to current practice guidelines. Written by practicing clinical pharmacists.
Actionable takeaways: how this evidence should (or should not) change your clinical approach, formulary decisions, patient counseling, or monitoring parameters. Practical, not theoretical.
Each weekly newsletter contains 3 studies following this exact format.
Fresh Evidence on Your Schedule
Choose how you want to receive your PACULit content. Whether you prefer to read daily or catch up all at once, we have you covered.
Drip Delivery (Default)
Receive one new study summary each on Monday, Wednesday, and Friday morning. Perfect for building a daily learning habit without feeling overwhelmed.
Monday — Study #1
Delivered at 6:00 AM ET
Wednesday — Study #2
Delivered at 6:00 AM ET
Friday — Study #3
Delivered at 6:00 AM ET
Weekly Digest (Sundays)
Prefer to batch your reading? Get all three studies compiled into one comprehensive Sunday morning digest. Ideal for dedicated weekend study sessions.
Sunday — Full Weekly Digest
Delivered at 8:00 AM ET
- All 3 study summaries
- All 3 audio summaries
- All CE quiz links
- Week-in-review highlights
Switch between drip and digest anytime in your account settings.
Tailored to Your Practice Area
Not all pharmacy literature is relevant to every pharmacist. When you subscribe, you choose your specialty tracks and receive content curated specifically for your practice area.
Critical Care
ICU, sepsis, ventilator management
Internal Medicine
General pharmacotherapy, chronic disease
Emergency Medicine
ED protocols, toxicology, rapid response
Infectious Disease
Antimicrobial stewardship, resistance
Ambulatory Care
Outpatient pharmacy, MTM, wellness
Select one or multiple tracks during signup. Your newsletter content will be weighted toward your chosen specialties, while still including landmark studies that every pharmacist should know.
See All FeaturesSee It in Action
Here is what a real PACULit Newsletter study summary looks like. This is the kind of evidence-based content subscribers receive every week.
Early Balanced Crystalloid vs. Normal Saline in Critically Ill Adults with Sepsis: A Multicenter Randomized Controlled Trial
New England Journal of Medicine. 2026;394(4):312-323. doi:10.1056/NEJMoa2603847
Key Findings
- Balanced crystalloid (lactated Ringer’s) reduced 30-day mortality by 2.8% compared to normal saline (22.1% vs. 24.9%; p=0.02) in septic ICU patients.
- Acute kidney injury requiring renal replacement therapy was lower in the balanced crystalloid group (8.2% vs. 11.4%; NNT=31).
- No significant difference in hyperkalemia, metabolic alkalosis, or other adverse electrolyte disturbances between groups.
Clinical Implications for Pharmacy
- This trial provides the strongest evidence to date supporting balanced crystalloids as the default resuscitation fluid in sepsis. Pharmacy & therapeutics committees should review institutional fluid protocols.
- Pharmacists in the ICU should advocate for formulary positioning of LR over NS for first-line sepsis resuscitation, with cost-neutrality as a supporting argument.
- Monitor renal function closely during the transition period; the renal-protective benefit may compound with other AKI-prevention bundles already in place.
Listen to Audio Summary
4:52 · Professional narration
Take CE Quiz
0.5 ACPE credits · 3 questions
Included with Every Plan
The PACULit Newsletter is available to all subscribers. Choose the plan that fits your career goals.
PACULit
Newsletter Included- PACULit Newsletter
- 3 curated studies/week
- Audio summaries
- CE credits included
- 5 specialty tracks
PACU Core
Newsletter Included- Everything in PACULit
- 100+ expert-led courses
- Pharmacotherapy libraries
- Clinical pearls database
- Priority support
Premium
Newsletter Included- Everything in Core
- BCPS/BCCCP/BCEMP prep
- Practice exams
- Structured study plans
- 1-on-1 mentor access
Subscribe to PACULit
Stop drowning in literature. Start mastering it.
Join thousands of pharmacists who stay current with the evidence that matters — delivered weekly, with audio summaries and CE credits included.
Free 7-day trial · Cancel anytime · All plans include the newsletter
Related Pages